FTRE
BUYNeutralComposite
65.70
Technical
96.40
Fundamental
45.20
Rank
—
Price
20.40
Hurst
0.41
As of
Jul 30, 2026
Daily
Fortrea Holdings Inc.
HealthcareBiotechnologyFortrea Holdings Inc. is a contract research organization that assists pharmaceutical, biotechnology, and medical device companies with development and testing of their products. The company provides services across multiple areas, including clinical pharmacology studies, clinical trial management from early through late-stage phases, regulatory compliance support, patient recruitment, data analysis, and post-market safety monitoring. It also offers consulting services related to product development, regulatory strategy, market access, and real-world evidence analysis.
Market cap
$1.9B
P/E (trailing)
—
P/E (forward)
17.51
PEG ratio
0.34
Dividend yield
—
Beta
1.95
52w range
8.31 – 21.39
Return on equity
-15.30%
Profit margin
-3.18%
Revenue growth
-4.50%
Earnings growth
—
Price history
1Y: 19.93 (+96.7%) · range 8.40–20.70
Cycle position
61/ 100 cycle scoreMID-BULL
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 8 · NOT READY · exit proximity 15
Conviction
34/ 100 · maturity 100%
VScore.4027
Buildup.2070
EMA entry setup.258
Fundamentals.1545
Volume profile
POC
17.67
Price vs POC
+12.8%
Overhead supply
7%
Runway
open sky
Value area 14.71–20.62 · 7% of 120d volume overhead · clean runway
Contributing sources
| Source | Score | Last seen |
|---|---|---|
| squeeze-risk | 0.358 | Sep 14, 2026 |
| short-interest | 0.203 | Sep 14, 2026 |
Forward returns
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | -1.15% | +2.31% | mature |
| 40d | -9.85% | +2.31% | 30/40d |